828,377 Shares in ASP Isotopes Inc. $ASPI Acquired by Man Group plc

Man Group plc acquired a new stake in shares of ASP Isotopes Inc. (NASDAQ:ASPI) in the second quarter, HoldingsChannel reports. The firm acquired 828,377 shares of the company’s stock, valued at approximately $5,153,000.

Several other hedge funds also recently bought and sold shares of ASPI. Jupiter Topco LLC bought a new stake in shares of ASP Isotopes during the second quarter worth $243,000. AWM Investment Company Inc. bought a new position in shares of ASP Isotopes in the second quarter worth about $9,837,000. Legal & General Group Plc bought a new position in shares of ASP Isotopes in the second quarter worth about $541,000. The Manufacturers Life Insurance Company bought a new position in shares of ASP Isotopes in the second quarter worth about $191,000. Finally, Sanctuary Advisors LLC purchased a new position in ASP Isotopes in the 2nd quarter worth about $200,000. Institutional investors own 16.80% of the company’s stock.

ASP Isotopes Stock Performance

Shares of ASP Isotopes stock opened at $3.88 on Monday. The firm has a market cap of $594.84 million, a P/E ratio of -2.94 and a beta of 3.61. The company has a current ratio of 3.87, a quick ratio of 3.85 and a debt-to-equity ratio of 0.76. ASP Isotopes Inc. has a 12 month low of $3.51 and a 12 month high of $14.49. The stock’s fifty day moving average price is $4.66 and its 200-day moving average price is $5.25.

ASP Isotopes (NASDAQ:ASPI) last released its quarterly earnings data on Friday, August 14th. The company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.17) by ($0.11). ASP Isotopes had a negative net margin of 427.98% and a negative return on equity of 64.99%. The firm had revenue of $5.12 million during the quarter, compared to the consensus estimate of $4.47 million.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on ASPI shares. Wall Street Zen upgraded shares of ASP Isotopes from a “strong sell” rating to a “sell” rating in a report on Saturday, August 22nd. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research report on Wednesday, June 24th. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $13.00.

Insider Buying and Selling at ASP Isotopes

In other news, CFO Heather Kiessling sold 23,124 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $6.28, for a total value of $145,218.72. Following the completion of the sale, the chief financial officer owned 1,526,252 shares of the company’s stock, valued at approximately $9,584,862.56. This represents a 1.49% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Todd Wider sold 50,000 shares of the stock in a transaction that occurred on Monday, June 29th. The shares were sold at an average price of $6.25, for a total transaction of $312,500.00. Following the transaction, the director owned 722,247 shares in the company, valued at approximately $4,514,043.75. This represents a 6.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 279,079 shares of company stock worth $2,049,208. 14.40% of the stock is currently owned by company insiders.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.